The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
@article{Nielsen2018TheUO, title={The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews}, author={S. Nielsen and Rada Germanos and M. Weier and J. Pollard and L. Degenhardt and W. Hall and N. Buckley and M. Farrell}, journal={Current Neurology and Neuroscience Reports}, year={2018}, volume={18}, pages={1-12} }
Purpose of ReviewPharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoids have been investigated for their therapeutic potential in treating multiple sclerosis (MS) symptoms. This review of reviews aimed to synthesise findings from high quality systematic reviews that examined the safety and effectiveness of cannabinoids in multiple sclerosis. We examined the outcomes of disability and disability progression, pain, spasticity, bladder function… CONTINUE READING
Figures and Topics from this paper
Figures
Paper Mentions
Interventional Clinical Trial
This study evaluates the combination of a CBD or THC/CBD capsule and an anti-inflammatory
diet in the treatment of neuropathic pain in spinal cord injuries. In the first part of the… Expand
Conditions | Neuropathic Pain, Spinal Cord Injuries |
---|---|
Intervention | Drug, Other |
News Article
44 Citations
Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: what is the evidence?
- Medicine
- Developmental medicine and child neurology
- 2020
- 1
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis
- Medicine
- Canadian journal of psychiatry. Revue canadienne de psychiatrie
- 2019
- 3
The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence
- Medicine
- Current Pain and Headache Reports
- 2020
- 10
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
- Medicine
- Pain and Therapy
- 2019
- 27
- PDF
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain
- Medicine
- European Archives of Psychiatry and Clinical Neuroscience
- 2018
- 15
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
- Medicine
- Cancers
- 2019
- 11
- PDF
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
- Medicine
- Medicines
- 2018
- 7
- Highly Influenced
- PDF
References
SHOWING 1-10 OF 44 REFERENCES
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
- Medicine
- BMC neurology
- 2009
- 74
- PDF
Adverse effects of medical cannabinoids: a systematic review
- Medicine
- Canadian Medical Association Journal
- 2008
- 251
- PDF
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
- Medicine
- The Lancet
- 2003
- 678
- PDF
Cannabinoids in medicine: A review of their therapeutic potential.
- Medicine
- Journal of ethnopharmacology
- 2006
- 165
- PDF
Cannabinoids in the treatment of movement disorders: A systematic review of case series and clinical trials
- Medicine
- 2016
- 11
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis
- Medicine
- Canadian journal of psychiatry. Revue canadienne de psychiatrie
- 2019
- 3
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders
- Medicine
- Neurology
- 2014
- 278
- PDF